Lung Cancer Trial, Recruiting NCT06688422 Sponsor: The Cooper Health System Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06688422
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with advanced non-small-cell lung cancer that has spread or cannot be removed with surgery.
  • People who are generally well enough to carry out everyday activities with little to no limitation (this is measured using a standard medical scale called ECOG, and a score of 0 or 1 is required).
  • People whose doctors consider them suitable to receive both chemotherapy and radiation treatment at the same time.
  • People who are 18 years of age or older.

Who may not be able to join:

  • People who have previously had surgery on their lungs or chest area.
  • People who are already enrolled in another clinical trial involving a lung-related treatment.
  • People who were using home oxygen before joining the trial.
  • People whose scans show certain lung or chest conditions, such as fluid around the lungs, a collapsed lung, large air pockets in the lungs, or lung inflammation.
  • People who currently have an active infection in their airways or lungs.
  • People experiencing nausea and vomiting that is not well controlled.
  • People who have previously been treated with certain medications, including amiodarone, bleomycin, or immunotherapy drugs.
  • People who are unable or unwilling to provide written consent to participate in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 856-735-6100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Cooper Health System
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of Pneumonitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov